Fever, a common symptom across various clinical scenarios, requires keen attention and understanding for effective management. This article provides a comprehensive guide to managing fever in clinical practice, addressing its etiology, assessment, and treatment strategies.
Fever is a physiological response to a variety of conditions, most commonly infections. Other causes include malignancies, autoimmune disorders, and certain medications. Understanding the underlying cause is crucial to guide the treatment plan.
Assessment starts with a thorough history and physical examination, focusing on the onset, pattern, and associated symptoms of the fever. Laboratory tests, including complete blood count, blood cultures, and inflammatory markers, can provide further insight. Imaging studies may be required based on the clinical context.
Treatment of fever primarily involves addressing the underlying cause. Antipyretics, such as acetaminophen and nonsteroidal anti-inflammatory drugs, are commonly used to alleviate discomfort. However, their use should be judicious, keeping in mind potential side effects. In the case of infectious causes, appropriate antimicrobial therapy is warranted.
Special populations, such as infants, the elderly, and immunocompromised patients, may present atypically and require a tailored approach. Additionally, febrile seizures, a potential complication in children, necessitate prompt intervention and follow-up.
Fever of unknown origin (FUO) poses a diagnostic challenge. It necessitates a systematic and exhaustive workup, often involving multiple specialties. A stepwise approach, starting with non-invasive tests and proceeding to invasive ones if necessary, is recommended.
In conclusion, fever management requires a comprehensive understanding of its etiology, a thorough assessment, and a tailored treatment approach. Special considerations should be taken into account for certain populations. FUO remains a challenge, emphasizing the need for a systematic and collaborative approach.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation